$33.72
-0.78-2.26%
At Close: -
$33.72
00.00%
After Hours: Jul 5, 4:00 PM EDT
15 minutes delayed
Protagonist Therapeutics
PTGXNASDAQ
Protagonist Therapeutics (NASDAQ:PTGX) Stock, Insider Trading Activity
Protagonist Therapeutics: Insider buying and selling updated today.
Institutional Shares Held
19.885M
Institutional Percentage Held
33.9%
| Jun 11, 2024 | William D Waddill | DIRECTOR | 0 | $23.94 | -$176.96K | SELL-OPTIONS | 0.00% | 12K | Jun 07 | View |
| Jun 11, 2024 | Dinesh V. Patel, Ph.D. | PRESIDENT AND CEO | -35K | $35.19 | -$1.23M | SELL | -6.36% | 515.415K | Jun 07 | View |
| Apr 19, 2024 | Asif Ali | CHIEF FINANCIAL OFFICER | -1.234K | $25.11 | -$30.99K | SELL | -3.21% | 37.163K | Apr 18 | View |
| Apr 02, 2024 | Dinesh V. Patel, Ph.D. | PRESIDENT AND CEO | -25K | $28.31 | -$707.75K | SELL | -4.35% | 549.59K | Apr 01 | View |
| Mar 01, 2024 | Dinesh V. Patel, Ph.D. | PRESIDENT AND CEO | -30K | $31.62 | -$948.60K | SELL | -4.96% | 574.59K | Mar 01 | View |
| Mar 01, 2024 | William D Waddill | DIRECTOR | 0 | $18.71 | -$327.62K | SELL-OPTIONS | 0.00% | 12K | Mar 01 | View |
| Mar 01, 2024 | Asif Ali | CHIEF FINANCIAL OFFICER | -12.187K | $21.89 | -$618.33K | SELL | -24.09% | 38.397K | Feb 29 - Mar 01 | View |
| Jan 11, 2024 | Suneel Gupta | CHIEF DEVELOPMENT OFFICER | 0 | $16.19 | -$88.10K | SELL-OPTIONS | 0.00% | 187.567K | Jan 09 | View |
| Jan 04, 2024 | Arturo Molina, MD | CHIEF MEDICAL OFFICER | 24.402K | $16.24 | -$30.01K | GRANT | 100.11% | 48.777K | Nov 15 - Jan 02 | View |
| Dec 15, 2023 | Dinesh V. Patel, Ph.D. | PRESIDENT AND CEO | -75K | $20.08 | -$1.51M | SELL | -12.31% | 534.347K | Dec 13 | View |
| Dec 23, 2021 | Dinesh V. Patel Ph.D. | PRESIDENT AND CEO | -15K | $32.14 | -$482.17K | SELL | -3.05% | 477.158K | Dec 21 | View |
| Aug 19, 2021 | David Y Liu | CHIEF SCIENTIFIC OFFICER | -4.779K | $24.21 | -$694.19K | SELL | -7.58% | 58.254K | Aug 17 | View |
| Feb 12, 2021 | Sarah B Noonberg | DIRECTOR | 0 | $16.14 | -$153.92K | GRANT | 0.00% | 0 | Feb 10 - Feb 11 | View |
| Jan 20, 2021 | Dinesh V. Patel, Ph.D. | PRESIDENT AND CEO | -11.846K | $14.40 | -$556.37K | SELL | -2.70% | 426.144K | Jan 19 | View |
| Aug 12, 2020 | Chaitan Khosla | — | 0 | $9.54 | -$38.23K | OPTION EXERCISE | 0.00% | 0 | Aug 11 | View |
| Mar 12, 2020 | Harold E Selick | — | 12K | $6.70 | $80.40K | PURCHASE | 362.54% | 15.31K | Mar 12 | View |
| Dec 03, 2019 | Bryan Giraudo | DIRECTOR | 8K | $5.70 | $45.62K | BUY | 80.00% | 18K | Dec 03 | View |
| Dec 03, 2019 | Suneel Gupta | EVP CLINICAL OPERATIONS | 30K | $5.13 | $153.90K | BUY | 153.85% | 49.5K | Dec 03 | View |
| Dec 03, 2019 | Donald A Kalkofen | CHIEF FINANCIAL OFFICER | 1.175K | $5.10 | $5.99K | BUY | ∞ | 1.175K | Dec 03 | View |
| Dec 03, 2019 | Dinesh V. Patel, Ph.D. | PRESIDENT AND CEO | 30K | $5.62 | $168.50K | BUY | 7.90% | 409.824K | Dec 03 | View |
| Aug 08, 2019 | David Y Liu | CHIEF SCIENTIFIC OFFICER | -3.395K | $8.85 | -$30.04K | SELL | -6.38% | 49.802K | Aug 06 | View |
| Aug 08, 2019 | Dinesh V. Patel, Ph.D. | PRESIDENT AND CEO | -10.792K | $8.85 | -$95.54K | SELL | -2.80% | 374.792K | Aug 06 | View |
FAQ
Is insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.